When you work as an Analyst II at KCAS in the method development team, you get to further our mission by being part of a of a growing team that is responsible for helping to develop methods for both large and small molecule assays utilizing skills including sample prep, instrumentation, and data analysis; with a focus in LC-MS/MS quantification or targeted proteomics.
In this roll, we will rely on you to:
- Contribute to all phases of assigned projects including sample preparation (extractions, enrichments/affinity capture, digestions), method development and qualification for LCMS, troubleshooting, data analysis and report generation
- Work with a lead scientist to identify critical experiments and deliver results
- Able to set up and change instrument configurations for various LCMS methods
- Prepare data summaries for senior scientists to aid in client updates
To qualify for this roll, you will have:
- BS/BA degree in Chemistry, Biochemistry, chemical/biochemical engineering, or related field
- Experience with wet chemistry
- This is an entry level position, but some experience with LCMS or analytical techniques, experience with Proteins, Peptides, and Immunoaffinity is a plus
Skills Required
- BS/BA degree in Chemistry, Biochemistry, Chemical/Biochemical Engineering, or related field
- Experience with wet chemistry
- Ability to perform sample preparation (extractions, enrichments/affinity capture, digestions)
- Method development and qualification for LC-MS/MS
- Troubleshooting and instrument configuration for LC-MS/MS
- Data analysis and report generation for analytical assays
- Experience with LCMS or analytical techniques
- Experience with proteins, peptides, and immunoaffinity techniques
What We Do
With its presence in three locations across North America and Europe, KCAS Bio is a leading contract research organization (CRO) employing top scientific talent and providing comprehensive bioanalytical services to the global biopharmaceutical industry from early discovery support through product registration and beyond. The collaboration of the three entities allows for global support in bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management. The KCAS family of companies operates in state-of-the-art facilities in the United States and Europe. This business structure enables the expertise, capacity, and flexibility to support the development of all types of drugs, biologics, cell and gene therapies to improve health worldwide. Our purpose is to help accelerate the discovery and development of life-changing drugs smoothly, safely and sustainably.
